Journals / Arşiv Kaynak Tarama Dergisi / 2016 / Cilt: 25 Sayı: 3

Thrombocytopenia in Pregnancy

Gebelikte Trombositopeni

Pages
420–432
Publication Date
2016-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The clinician should be able to distinguish between thrombocytopenia that does not require treatment and the causes that require emergent and serious medical interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thrombocytopenia, which is encountered in 7-10% of pregnancies is characterized with decreased number of thrombocytes.
📊
Key Findings & Data:The most frequent cause of thrombocytopenia during pregnancy is gestational thrombocytopenia.
💡
Conclusion & Impact:The clinician should be able to distinguish between thrombocytopenia that does not require treatment and the causes that require emergent and serious medical interventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Trombositopeni · gebelik · otoimmün hemolitik anemi

Abstract

Thrombocytopenia, which is encountered in 7-10% of pregnancies is characterized with decreased number of thrombocytes. The most frequent cause of thrombocytopenia during pregnancy is gestational thrombocytopenia. These patients usually do not have symptoms due to mild thrombocytopenia. The diagnosis is usually established by excluding connective tissue disorders, drug effects and obstetric causes. The etiology of thrombocytopenia during early pregnancy is most frequently due to autoimmune causes. Thrombocytopenia secondary to obstetric causes like preeclampsia, HELLP syndrome should always be kept in mind. Under these circumstances the thrombocytopenia will not resolve unless pregnancy is terminated. The clinician should be able to distinguish between thrombocytopenia that does not require treatment and the causes that require emergent and serious medical interventions.

Özet

Trombositopeni gebeliklerin %7-10’unda saptanan, trombosit sayısının düşüklüğüyle karakterize bir durumdur. Gebelikte görülen trombositopenin en sık sebebi gestasyonel trombositopenidir. Bu hastalarda trombositopeni genelde hafif olduğundan semptom görülmez. Tanı çoğunlukla bağ dokusu hastalıklarının,ilaç etkilerinin, obstetriyle ilişkili sebeplerin dışlanmasıyla konulur. Erken gebelik haftalarında görülen trombositopenin etyolojisinde en fazla otoimmun sebepler rol alır. Preeklampsi,HELLP sendromu gibi obstetriyle ilişkili nedenlere ikincil gelişen trombositopeniler ise her zaman akılda tutulmalıdır. Bu durumların varlığında çoğu zaman doğum gerçekleşmeden trombositopeni düzelmeyecektir. Klinisyen; tedavi gerektirmeyen trombositopenilerle, annenin fetusun hayatını tehdit eden ve bu nedenle acil ve ciddi bakım gerektiren trombositopeni sebepleri arasında ayırımı iyi yapabilmelidir.

🔖

Cite This Article

Özsürmeli, M., Sucu, M., Çetin, C., KHATİB, G., DEMİR, C. (2016). Thrombocytopenia in Pregnancy. Arşiv Kaynak Tarama Dergisi, Cilt: 25 Sayı: 3, 420–432. https://ajindex.com/articles/924495

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Myers B. Diagnosis and management of maternal thrombocytopenia in pregnancy.Br J Haematol. 2012;158:3-15.
  2. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329:1463-6. Adams TM,Allaf MB, Vintzileos AM. Maternal thrombocytopenia in pregnancy: diagnosis and management. Clin Lab Med. 2013;33:327-41.
  3. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162:731–4.
  4. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:3-40.
  5. Silver RM, Branch DW, Scott JR. Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol. 1995;173:479–82.
  6. Allford SL, Hunt BJ, Rose P, Machin SJ. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol. 2003;120:556-73.
  7. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-207.
  8. Segal JP, Powe NR. Prevalence of immune thrombocytopenia: analysis of administrative data. J Thromb Haemost. 2006;4:237–83.
  9. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11 year analysis of obstetric patients with idiopathic thrombocytopenia purpura. Blood. 2003;102:4306–11.
  10. Payne SR, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol.1997;177:149–55. Ünüvar A. Çocukluk çağında primer immün trombositopeni. Turkiye Klinikleri J Hematol-Special Topics. 2014;7:46-59
  11. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med. 1990; 26:229-35.
  12. Şahin Ş, Bingöl U, Özsoy ZA,Taşlıyurt T. Gebelikte trombositopeni. Abant Med J. 2014;3:99-104. ACOG practice bulletin: Thrombocytopenia in pregnancy. Number 6, September 1999. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1999;67:117-28.
  13. Samama CM, Bastien O, Forestier F, Denninger MH, Isetta C, Jul